Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoliina Stefanius

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Genetics & Development|January 21, 2021
Exosomes in cancer developmentKaroliina Stefanius, Kelly Servage, Kim Orth
Scientific Reports|May 9, 2020
Proteomic Profiling of Small Extracellular Vesicles Secreted by Human Pancreatic Cancer Cells Implicated in Cellular TransformationKelly A Servage, Karoliina Stefanius, Hillery Fields Gray, et al.
Histopathology|April 5, 2011
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinomaKaroliina Stefanius, Laura Ylitalo, Anne Tuomisto, et al.
Virchows Archiv : an International Journal of Pathology|January 15, 2011
Downregulation of the hedgehog receptor PTCH1 in colorectal serrated adenocarcinomas is not caused by PTCH1 mutationsKaroliina Stefanius, Tiina Kantola, Anne Tuomisto, et al.
Elife|May 29, 2019
Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformationKaroliina Stefanius, Kelly Servage, Marcela de Souza Santos, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2014
Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesisShan-Shan Wang, Yi-Feng Gu, Nicholas Wolff, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2022
Fic-mediated AMPylation tempers the unfolded protein response during physiological stressAmanda K Casey, Hillery F Gray, Suneeta Chimalapati, et al.
Urologic Oncology|December 4, 2014
Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinomaThai H Ho, Payal Kapur, Richard W Joseph, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Genetics & Development|January 21, 2021
Exosomes in cancer developmentKaroliina Stefanius, Kelly Servage, Kim Orth
Scientific Reports|May 9, 2020
Proteomic Profiling of Small Extracellular Vesicles Secreted by Human Pancreatic Cancer Cells Implicated in Cellular TransformationKelly A Servage, Karoliina Stefanius, Hillery Fields Gray, et al.
Histopathology|April 5, 2011
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinomaKaroliina Stefanius, Laura Ylitalo, Anne Tuomisto, et al.
Virchows Archiv : an International Journal of Pathology|January 15, 2011
Downregulation of the hedgehog receptor PTCH1 in colorectal serrated adenocarcinomas is not caused by PTCH1 mutationsKaroliina Stefanius, Tiina Kantola, Anne Tuomisto, et al.
Elife|May 29, 2019
Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformationKaroliina Stefanius, Kelly Servage, Marcela de Souza Santos, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2014
Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesisShan-Shan Wang, Yi-Feng Gu, Nicholas Wolff, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2022
Fic-mediated AMPylation tempers the unfolded protein response during physiological stressAmanda K Casey, Hillery F Gray, Suneeta Chimalapati, et al.
Urologic Oncology|December 4, 2014
Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinomaThai H Ho, Payal Kapur, Richard W Joseph, et al.
Pageof 1